Honduras: Dengue fever outbreak reported nationwide through August. Risk of transmission is highest in Metropolitan Central District /update 1

Event

Honduran authorities continue to report elevated dengue fever activity nationwide, with 6,433 additional cases reported June 27-Aug. 14, leading to 15,584 cases since Jan. 1. This caseload represents more than double the 6,537 cases reported over a similar period in 2021. Metropolitan Central District is the most affected area followed by Choluteca, Yoro, and El Paraiso. This report represents the most complete information available as of Aug. 25.

Context

Dengue fever is considered a year-round and nationwide threat in Honduras, where the risk is typically highest May-October. The risk of dengue fever transmission is higher in urban and semi-urban areas.

A dengue fever vaccine is available in some countries. It is only recommended for individuals with a history of dengue infection and in a country with high dengue fever burden. Dengue fever is transmitted through the bite of an infected mosquito. Symptoms of dengue fever include a sudden onset of fever and at least one of the following: severe headache, severe pain behind the eyes, muscle and/or joint pain, rash, easy bruising, and/or nose or gum bleeding. Symptoms typically appear 5-7 days after being bitten, but can develop up to 10 days after exposure. Dengue fever can progress to a more severe form known as dengue hemorrhagic fever (DHF). DHF can be fatal if it is not recognized and treated in a timely manner.

Advice

If you have previously been infected with dengue fever, consult with your physician regarding vaccination. Avoid mosquito bites and remove standing water to reduce the number of biting mosquitoes. Seek medical attention if symptoms develop within two weeks of being in affected areas. Do not use aspirin or ibuprofen products if dengue fever is suspected, as these could exacerbate bleeding tendencies associated with the disease.